Current methods of drug delivery employ systemic administration which result in numerous undesired side effects outside the targeted area. The electro osmotic pump THL is developing will be an implantable device capable of delivering pain medication to sensitive areas, anti-biotics to internal infections, and chemotherapy drugs to tumors or cancers. The device delivers the drug over a controllable and steady rate, with the ability to be turned on or shut off from outside the body. In addition to offering size efficiency and convenience, the device will reduce infection during drug delivery and lead to higher overall effectiveness in drug therapy.
